1. Pink Sheet

Erbitux Gets C-Code Reimbursement; Waits For Green Light On J-Code

 
• By Lee Kalowski

ImClone has not seen "obstacles" to reimbursement across all patients. During the quarter, Erbitux generated $17.5 mil. in sales.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Archive

More from Pink Sheet